Results 201 to 210 of about 24,743 (267)

Reevaluating Donor-recipient Sex Mismatch and Survival After Liver Transplantation: A Contemporary Cohort Study. [PDF]

Transplant Direct
Pollmann NS, Parmentier C, Rauchfuß F, Settmacher U, Pollmann L, Selzner M.   +5 more
europepmc   +1 more source

Late‐Stage Functionalization of Peptides on the Solid Phase

Angewandte Chemie International Edition, Volume 65, Issue 31, 27 July 2026.
Peptide modifications are essential to control pharmacodynamic and pharmacokinetic properties of peptide drugs. Consequently, strategies that allow for efficient and rapid incorporation of non‐canonical modifications into peptides in parallel formats are highly sought after.
Marius Werner, Truc Lam Pham, Franziska Thomas   +2 more
wiley   +1 more source

Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. [PDF]

Pak J Med Sci
Zuberi BF, Ali FS, Rasheed T, Bader N.
europepmc   +1 more source

From Risk to Balance: A Novel Approach Integrating Donor, Recipient, and Procedural Factors to Predict 12-Month Graft Loss in Liver Transplantation. [PDF]

J Clin Med
Lai Q, Sesa V, Melandro F, Silovski H, Baronica R, Ginanni Corradini S, Hanzek I, Mennini G, Cutic B, Rossi M, Mrzljak A.   +10 more
europepmc   +1 more source

The SOFT Cluster Score as a Multifaceted Predictive Model for Postoperative Outcomes. [PDF]

Transplant Direct
Henry GB, Kamepalli S, Burns CJ, Birkmire J, Cholankeril G, Flores A, Goss JA, Rana A.   +7 more
europepmc   +1 more source

Impact of housing instability on hospital outcomes in alcohol-associated liver disease: A single-center retrospective cohort study. [PDF]

Medicine (Baltimore)
Lee KJ, Fan GH, Huang A, Karagozian R, Almeqdadi M.   +4 more
europepmc   +1 more source

Upper Gastrointestinal Bleeding in Cirrhosis: Differential Performance of Risk Scores for In-Hospital Mortality and Intensive Care Unit Triage Decisions. [PDF]

Cureus
Ciorba IMI, Craciun Ciorba N, Bataga SM.
europepmc   +1 more source

Excluding Ascites From the GEMA-Na Score Does Not Impact Outcome Predictions in Liver Transplant Candidates. [PDF]

Liver Int
Rodríguez-Perálvarez ML, Gómez-Orellana AM, Majumdar A, McCaughan GW, Kalafateli M, Taylor R, de la Rosa G, Aguilera MV, Gastaca M, Cepeda-Franco C, Ortiz ML, Colmenero J, Otero A, González Grande R, Cachero A, Molina Pérez E, Barreales M, Martín Mateos R, Rodríguez-Soler M, Romero M, Dopazo C, Alonso Martín C, Otón E, González Diéguez L, Espinosa MD, Arias Milla A, Blanco Fernández G, Lorente S, Cuadrado Lavín A, Sogbe M, Guijo-Rubio D, Hervás Martínez C, Tsochatzis E.   +32 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MELD Score Calculator — LiverTracker Clinical Tool (MELD, MELD-Na, MELD 3.0)

A free, open-access clinical calculator implementing three validated MELD scoring systems (MELD, MELD-Na, MELD 3.0) used by transplant centres worldwide to assess liver disease severity and prioritise patients on the transplant waiting list. Implements formulas from Kamath et al. (2001), Kim et al. (2008), and Kim et al. (2021).
Priyam, Jyotsna, Vikash Kumar Tiwary
openaire   +1 more source